Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer: Evidence Assessment Group Perspective.
作者信息
Orozco-Leal Giovany, Johnson Eugenie Evelynne, Hosseinijebeli Sedighe, Robinson Tomos, Homer Tara, Eastaugh Claire H, Richmond Catherine, Tanner Louise, Meader Nick, Kenny Ryan, Wallace Sheila A, Rice Stephen
机构信息
Newcastle University, Newcastle upon Tyne, UK.
Clinical Effectiveness Librarian, Tyne and Wear NHS Foundation Trust, Gateshead, UK.
出版信息
Pharmacoeconomics. 2024 Feb;42(2):133-136. doi: 10.1007/s40273-023-01328-w. Epub 2023 Nov 20.
PMID:37985576
Abstract
摘要
Zotero 插件